TrialEuropean journal of neurology2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial.

Konrad Rejdak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.